Literature DB >> 10915100

Cytolethal distending toxin in avian and human isolates of Helicobacter pullorum.

V B Young1, C C Chien, K A Knox, N S Taylor, D B Schauer, J G Fox.   

Abstract

Helicobacter pullorum has been isolated from the feces and livers of poultry and is associated with human gastroenteritis. Discrimination of this organism from other enterohepatic Helicobacter species and Campylobacter species has proven difficult. H. pullorum from both avian and human clinical sources has DNA sequence homology and cytotoxic activity that represent a new member of the cytolethal distending toxin (CDT) family of bacterial toxins. CDT is a potential virulence factor in H. pullorum that may serve as a distinguishing phenotype and aid in identification of this organism in veterinary and human clinical samples.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10915100     DOI： 10.1086/315705

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  37 in total

1.  Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease.

Authors:  Ulrich R M Bohr; Bernhard Glasbrenner; Anett Primus; Alexandra Zagoura; Thomas Wex; Peter Malfertheiner
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells.

Authors:  Martina Bielaszewska; Bhanu Sinha; Thorsten Kuczius; Helge Karch
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Prevalence of Helicobacter pullorum in conventional, organic, and free-range broilers and typing of isolates.

Authors:  Gerardo Manfreda; Antonio Parisi; Alex Lucchi; Renato Giulio Zanoni; Alessandra De Cesare
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

4.  Immune responses to bile-tolerant helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors.

Authors:  Olga Ananieva; Ingrid Nilsson; Tamara Vorobjova; Raivo Uibo; Torkel Wadström
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 5.  Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages.

Authors:  Rasika N Jinadasa; Stephen E Bloom; Robert S Weiss; Gerald E Duhamel
Journal:  Microbiology (Reading)       Date:  2011-05-12       Impact factor: 2.777

6.  Helicobacter canadensis sp. nov. isolated from humans with diarrhea as an example of an emerging pathogen.

Authors:  J G Fox; C C Chien; F E Dewhirst; B J Paster; Z Shen; P L Melito; D L Woodward; F G Rodgers
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

7.  Keratinocyte growth factor-2 stimulates P-glycoprotein expression and function in intestinal epithelial cells.

Authors:  Seema Saksena; Shubha Priyamvada; Anoop Kumar; Maria Akhtar; Vikas Soni; Arivarasu Natarajan Anbazhagan; Anas Alakkam; Waddah A Alrefai; Pradeep K Dudeja; Ravinder K Gill
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-17       Impact factor: 4.052

8.  Avian reservoirs and zoonotic potential of the emerging human pathogen Helicobacter canadensis.

Authors:  Jonas Waldenström; Stephen L W On; Richard Ottvall; Dennis Hasselquist; Clare S Harrington; Björn Olsen
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

9.  In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants.

Authors:  Vincent B Young; Kimberly A Knox; Jason S Pratt; Jennifer S Cortez; Linda S Mansfield; Arlin B Rogers; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Simple sequence repeats in Helicobacter canadensis and their role in phase variable expression and C-terminal sequence switching.

Authors:  Lori A S Snyder; Nicholas J Loman; James D Linton; Rebecca R Langdon; George M Weinstock; Brendan W Wren; Mark J Pallen
Journal:  BMC Genomics       Date:  2010-01-27       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.